Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression

Hidetsugu Saito, Hirotoshi Ebinuma, Masahiko Takahashi, Fumihiko Kaneko, Kanji Wakabayashi, Mitsuyasu Nakamura, Hiromasa Ishii

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

We have demonstrated that sodium butyrate induces differentiation in human hepatoma cells; however, recent studies have shown that this agent causes apoptosis in some types of cancer cells. In this study, we examined whether sodium butyrate causes apoptosis in the human hepatoma cell lines, HCC-M and HCC-T. The growth of human hepatoma cells was dose-dependently reduced by sodium butyrate. Flow cytometric analysis showed cell-cycle arrest at the G1 phase in the sodium butyrate-treated cells. Apoptotic change was never found in treated cells at concentration levels of less than 5 mmol/L. Sodium butyrate decreased p53 expression and increased p21(waf-1) expression in Hcc-t and Hcc-m cells having the wild-type p53 gene. Western blot analysis showed that Bcl-2 was expressed in the Hcc-t and Hcc-m cells, and its expression was increased after exposure to sodium butyrate. Antisense oligodeoxynucleotide against bcl-2 easily caused apoptosis. These results indicate that sodium butyrate hardly induces apoptotic change in the human hepatoma cell lines, HCC-T and HCC-M, with the increase of Bcl-2 expression. Cell-cycle arrest in the G1 phase caused by sodium butyrate was suggested to be induced by the increase in p21(waf-1) expression, but this change did not link with the p53 increase.

Original languageEnglish
Pages (from-to)1233-1240
Number of pages8
JournalHepatology
Volume27
Issue number5
DOIs
Publication statusPublished - 1998

Fingerprint

Butyric Acid
Butyrates
Hepatocellular Carcinoma
Apoptosis
Cell Line
G1 Phase
Cell Cycle Checkpoints
p53 Genes
Western Blotting
Growth

ASJC Scopus subject areas

  • Hepatology

Cite this

Saito, H., Ebinuma, H., Takahashi, M., Kaneko, F., Wakabayashi, K., Nakamura, M., & Ishii, H. (1998). Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Hepatology, 27(5), 1233-1240. https://doi.org/10.1002/hep.510270508

Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. / Saito, Hidetsugu; Ebinuma, Hirotoshi; Takahashi, Masahiko; Kaneko, Fumihiko; Wakabayashi, Kanji; Nakamura, Mitsuyasu; Ishii, Hiromasa.

In: Hepatology, Vol. 27, No. 5, 1998, p. 1233-1240.

Research output: Contribution to journalArticle

Saito, H, Ebinuma, H, Takahashi, M, Kaneko, F, Wakabayashi, K, Nakamura, M & Ishii, H 1998, 'Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression', Hepatology, vol. 27, no. 5, pp. 1233-1240. https://doi.org/10.1002/hep.510270508
Saito, Hidetsugu ; Ebinuma, Hirotoshi ; Takahashi, Masahiko ; Kaneko, Fumihiko ; Wakabayashi, Kanji ; Nakamura, Mitsuyasu ; Ishii, Hiromasa. / Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. In: Hepatology. 1998 ; Vol. 27, No. 5. pp. 1233-1240.
@article{c6ff8add87f1428f8d03cf8e9b36c1d3,
title = "Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression",
abstract = "We have demonstrated that sodium butyrate induces differentiation in human hepatoma cells; however, recent studies have shown that this agent causes apoptosis in some types of cancer cells. In this study, we examined whether sodium butyrate causes apoptosis in the human hepatoma cell lines, HCC-M and HCC-T. The growth of human hepatoma cells was dose-dependently reduced by sodium butyrate. Flow cytometric analysis showed cell-cycle arrest at the G1 phase in the sodium butyrate-treated cells. Apoptotic change was never found in treated cells at concentration levels of less than 5 mmol/L. Sodium butyrate decreased p53 expression and increased p21(waf-1) expression in Hcc-t and Hcc-m cells having the wild-type p53 gene. Western blot analysis showed that Bcl-2 was expressed in the Hcc-t and Hcc-m cells, and its expression was increased after exposure to sodium butyrate. Antisense oligodeoxynucleotide against bcl-2 easily caused apoptosis. These results indicate that sodium butyrate hardly induces apoptotic change in the human hepatoma cell lines, HCC-T and HCC-M, with the increase of Bcl-2 expression. Cell-cycle arrest in the G1 phase caused by sodium butyrate was suggested to be induced by the increase in p21(waf-1) expression, but this change did not link with the p53 increase.",
author = "Hidetsugu Saito and Hirotoshi Ebinuma and Masahiko Takahashi and Fumihiko Kaneko and Kanji Wakabayashi and Mitsuyasu Nakamura and Hiromasa Ishii",
year = "1998",
doi = "10.1002/hep.510270508",
language = "English",
volume = "27",
pages = "1233--1240",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression

AU - Saito, Hidetsugu

AU - Ebinuma, Hirotoshi

AU - Takahashi, Masahiko

AU - Kaneko, Fumihiko

AU - Wakabayashi, Kanji

AU - Nakamura, Mitsuyasu

AU - Ishii, Hiromasa

PY - 1998

Y1 - 1998

N2 - We have demonstrated that sodium butyrate induces differentiation in human hepatoma cells; however, recent studies have shown that this agent causes apoptosis in some types of cancer cells. In this study, we examined whether sodium butyrate causes apoptosis in the human hepatoma cell lines, HCC-M and HCC-T. The growth of human hepatoma cells was dose-dependently reduced by sodium butyrate. Flow cytometric analysis showed cell-cycle arrest at the G1 phase in the sodium butyrate-treated cells. Apoptotic change was never found in treated cells at concentration levels of less than 5 mmol/L. Sodium butyrate decreased p53 expression and increased p21(waf-1) expression in Hcc-t and Hcc-m cells having the wild-type p53 gene. Western blot analysis showed that Bcl-2 was expressed in the Hcc-t and Hcc-m cells, and its expression was increased after exposure to sodium butyrate. Antisense oligodeoxynucleotide against bcl-2 easily caused apoptosis. These results indicate that sodium butyrate hardly induces apoptotic change in the human hepatoma cell lines, HCC-T and HCC-M, with the increase of Bcl-2 expression. Cell-cycle arrest in the G1 phase caused by sodium butyrate was suggested to be induced by the increase in p21(waf-1) expression, but this change did not link with the p53 increase.

AB - We have demonstrated that sodium butyrate induces differentiation in human hepatoma cells; however, recent studies have shown that this agent causes apoptosis in some types of cancer cells. In this study, we examined whether sodium butyrate causes apoptosis in the human hepatoma cell lines, HCC-M and HCC-T. The growth of human hepatoma cells was dose-dependently reduced by sodium butyrate. Flow cytometric analysis showed cell-cycle arrest at the G1 phase in the sodium butyrate-treated cells. Apoptotic change was never found in treated cells at concentration levels of less than 5 mmol/L. Sodium butyrate decreased p53 expression and increased p21(waf-1) expression in Hcc-t and Hcc-m cells having the wild-type p53 gene. Western blot analysis showed that Bcl-2 was expressed in the Hcc-t and Hcc-m cells, and its expression was increased after exposure to sodium butyrate. Antisense oligodeoxynucleotide against bcl-2 easily caused apoptosis. These results indicate that sodium butyrate hardly induces apoptotic change in the human hepatoma cell lines, HCC-T and HCC-M, with the increase of Bcl-2 expression. Cell-cycle arrest in the G1 phase caused by sodium butyrate was suggested to be induced by the increase in p21(waf-1) expression, but this change did not link with the p53 increase.

UR - http://www.scopus.com/inward/record.url?scp=0031970937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031970937&partnerID=8YFLogxK

U2 - 10.1002/hep.510270508

DO - 10.1002/hep.510270508

M3 - Article

VL - 27

SP - 1233

EP - 1240

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -